The 2-day Making Pharmaceuticals event is designed to help the pharmaceutical industry improve manufacturing processes, address product formulation/reformulation, reduce undesired variability, deliver consistent product quality, improve process robustness and enhance efficiency.


Upon the request from the event organisers, Jonathan Burd, product director at Formpipe Life Science division, will deliver a 20-minute presentation on the benefits of the Cloud in relation to quality assurance and compliance management. As part of this presentation, which is entitled ‘An introduction to the GxP Cloud; Risks, regulatory considerations and vendor assessment’, Jonathan will discuss the role of an EQMS and how businesses should prepare for using the Cloud on GxP applications. Within the presentation he will give delegates an understanding of what the Cloud encompasses, the advantages and disadvantages of using it, the special features of Cloud in GxP environments, what delegates should expect from their Cloud provider and what models they should consider.


Commenting on being chosen to deliver a presentation at Making Pharmaceuticals, Jonathan said: “The Cloud remains unchartered territory for many naturally risk adverse organisations in the pharmaceutical sector. Yet, if approached and implemented with understanding, the benefits the Cloud is capable of delivering to the quality assurance and compliance management agenda are significant. Yes, there are risks and yes there are specific regulatory hurdles to overcome but these can all be mitigated and benefits quickly realised by migrating systems and processes to the Cloud.”


The presentation will take place on Tuesday 26th April at 2pm in room A. A question and answer session will be available immediately after the presentation. Representatives of Formpipe Life Science division will be available to answer any questions and provide expert advice during the event on stand 103. For more information, please visit or